Engin Narinc

Engin Narinc serves as CEO at VISION Biotechnology. VISION Biotechnology operates in the research sector with approximately 22.0 employees. The company is headquartered in Istanbul.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 1,026 executive contacts are available in Istanbul.
• • Our database includes 201,469 c suite-level executives.

Gmail Google Apps Microsoft Office 365 Google Cloud Hosting Varnish Wix Mobile Friendly Render

biotechnology research diagnostic test kits real-time pcr test kits lfa rapid test kits nucleic acid extraction kits microbiology panels blood grouping laboratory developed tests hmpv testing monkeypox detection multiplex qpcr assays antibiotic resistance gene panel sexually transmitted infections panel urinary tract infections panel gastroenteritis panel respiratory pathogens panel viral detection kits bacterial detection kits fungal detection kits genotyping kits covid-19 testing pneumonia detection hepatitis detection tropical disease screening environmental testing sample collection lab automation systems clinical diagnostics biotechnology advancements patient diagnosis enhancement rapid antigen tests serology tests public health diagnostics disease outbreak response infection control genetic disease screening early detection techniques healthcare professional tools lab efficiency quality assurance in testing biomedical research solutions comprehensive diagnostic solutions biomedical testing clinical laboratory supplies healthcare technology medical diagnostics research & development precision healthcare lab consumables medical device innovations

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Engin Narinc in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at VISION Biotechnology.

Engin Narinc's Position in the MessageCEO Database

• •Engin Narinc is 1 of 1 verified executive contact we track at VISION Biotechnology.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •1,019 verified executive contacts in Istanbul are in the database.
• •48 verified contacts work at research companies in the 22.0 employee range (same size as VISION Biotechnology).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.

How do I reach Engin Narinc directly?

Engin Narinc's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at VISION Biotechnology. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Engin Narinc work for?

Engin Narinc is CEO at VISION Biotechnology, a company in the research sector with 22.0 employees. The company is based in Istanbul.

Can I pitch or sell to Engin Narinc?

As CEO at VISION Biotechnology, Engin Narinc is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Engin Narinc directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Engin Narinc in?

Engin Narinc works in the research industry as CEO at VISION Biotechnology. MessageCEO provides verified contact information for executives across all major industries.

Is Engin Narinc's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Engin Narinc's profile is kept up-to-date with the latest available information.

Last updated: June 22, 2026